FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2285208450> ?p ?o ?g. }

• W2285208450 endingPage "861" @default.
• W2285208450 startingPage "856" @default.
• W2285208450 abstract "Sorafenib (S), a multitargeted tyrosine kinase inhibitor, is the standard of care for first-line systemic treatment of advanced hepatocellular carcinoma (HCC). Everolimus (E) is a potent inhibitor of mTOR, a pathway frequently activated in HCC. Preclinical data suggest that the combination S + E has additive effects compared with single-agent S.Patients with unresectable or metastatic HCC and Child-Pugh ≤7 liver dysfunction were randomized to receive daily S 800 mg alone or with E 5 mg until progression or unacceptable toxicity. The primary end point was progression-free survival at 12 weeks (PFS12). The secondary end points included response rate, PFS, time to progression (TTP), overall survival (OS), duration of disease stabilization (DDS), safety, and quality-of-life (QoL) assessments.A total of 106 patients were randomized: 46 patients received S and 60 patients received S + E. Ninety-three patients were assessable for the primary end point and 105 patients for the safety analysis. The PFS12 rate was 70% [95% confidence interval (CI) 54-83] and 68% (95% CI 53-81) in patients randomized to S and S + E, respectively. The RECIST (mRECIST) response rate was 0% (23%) in the S arm and 10% (35%) in the S + E arm. Median PFS (6.6 versus 5.7 months), TTP (7.6 versus 6.3 months), DDS (6.7 versus 6.7 months), and OS (10 versus 12 months) were similar in the S and S + E arms, respectively. Grade 3/4 adverse events occurred in 72% and 86% of patients in arm S and arm S + E, respectively. Patients had similar QoL scores over time, except for a greater worsening in physical well-being and mood in the arm S + E.No evidence was found that S + E improves the efficacy compared with S alone. Combining 5 mg E with full-dose S is feasible, but more toxic than S alone. Further testing of this drug combination in molecularly unselected HCCs appears unwarranted.NCT01005199." @default.
• W2285208450 created "2016-06-24" @default.
• W2285208450 creator A5005951305 @default.
• W2285208450 creator A5008022418 @default.
• W2285208450 creator A5012453950 @default.
• W2285208450 creator A5020167411 @default.
• W2285208450 creator A5020295006 @default.
• W2285208450 creator A5031517983 @default.
• W2285208450 creator A5033985179 @default.
• W2285208450 creator A5035051777 @default.
• W2285208450 creator A5035910205 @default.
• W2285208450 creator A5039207289 @default.
• W2285208450 creator A5057388668 @default.
• W2285208450 creator A5060531617 @default.
• W2285208450 creator A5062916168 @default.
• W2285208450 creator A5071282635 @default.
• W2285208450 creator A5073880705 @default.
• W2285208450 creator A5081788714 @default.
• W2285208450 creator A5087142746 @default.
• W2285208450 creator A5087589439 @default.
• W2285208450 date "2016-05-01" @default.
• W2285208450 modified "2023-10-18" @default.
• W2285208450 title "Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)" @default.
• W2285208450 cites W1971837077 @default.
• W2285208450 cites W1986359215 @default.
• W2285208450 cites W1994193851 @default.
• W2285208450 cites W2004274458 @default.
• W2285208450 cites W2019607817 @default.
• W2285208450 cites W2029336551 @default.
• W2285208450 cites W2048177238 @default.
• W2285208450 cites W2065649212 @default.
• W2285208450 cites W2079586464 @default.
• W2285208450 cites W2108621560 @default.
• W2285208450 cites W2120113475 @default.
• W2285208450 cites W2123534406 @default.
• W2285208450 cites W2123546830 @default.
• W2285208450 cites W2126888987 @default.
• W2285208450 cites W2128965737 @default.
• W2285208450 cites W2151062731 @default.
• W2285208450 cites W2153935627 @default.
• W2285208450 cites W2154684650 @default.
• W2285208450 cites W2165901246 @default.
• W2285208450 cites W2267051348 @default.
• W2285208450 cites W2590482740 @default.
• W2285208450 doi "https://doi.org/10.1093/annonc/mdw054" @default.
• W2285208450 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26884590" @default.
• W2285208450 hasPublicationYear "2016" @default.
• W2285208450 type Work @default.
• W2285208450 sameAs 2285208450 @default.
• W2285208450 citedByCount "95" @default.
• W2285208450 countsByYear W22852084502015 @default.
• W2285208450 countsByYear W22852084502016 @default.
• W2285208450 countsByYear W22852084502017 @default.
• W2285208450 countsByYear W22852084502018 @default.
• W2285208450 countsByYear W22852084502019 @default.
• W2285208450 countsByYear W22852084502020 @default.
• W2285208450 countsByYear W22852084502021 @default.
• W2285208450 countsByYear W22852084502022 @default.
• W2285208450 countsByYear W22852084502023 @default.
• W2285208450 crossrefType "journal-article" @default.
• W2285208450 hasAuthorship W2285208450A5005951305 @default.
• W2285208450 hasAuthorship W2285208450A5008022418 @default.
• W2285208450 hasAuthorship W2285208450A5012453950 @default.
• W2285208450 hasAuthorship W2285208450A5020167411 @default.
• W2285208450 hasAuthorship W2285208450A5020295006 @default.
• W2285208450 hasAuthorship W2285208450A5031517983 @default.
• W2285208450 hasAuthorship W2285208450A5033985179 @default.
• W2285208450 hasAuthorship W2285208450A5035051777 @default.
• W2285208450 hasAuthorship W2285208450A5035910205 @default.
• W2285208450 hasAuthorship W2285208450A5039207289 @default.
• W2285208450 hasAuthorship W2285208450A5057388668 @default.
• W2285208450 hasAuthorship W2285208450A5060531617 @default.
• W2285208450 hasAuthorship W2285208450A5062916168 @default.
• W2285208450 hasAuthorship W2285208450A5071282635 @default.
• W2285208450 hasAuthorship W2285208450A5073880705 @default.
• W2285208450 hasAuthorship W2285208450A5081788714 @default.
• W2285208450 hasAuthorship W2285208450A5087142746 @default.
• W2285208450 hasAuthorship W2285208450A5087589439 @default.
• W2285208450 hasBestOaLocation W22852084501 @default.
• W2285208450 hasConcept C126322002 @default.
• W2285208450 hasConcept C126894567 @default.
• W2285208450 hasConcept C141071460 @default.
• W2285208450 hasConcept C141341695 @default.
• W2285208450 hasConcept C143998085 @default.
• W2285208450 hasConcept C168563851 @default.
• W2285208450 hasConcept C197934379 @default.
• W2285208450 hasConcept C203092338 @default.
• W2285208450 hasConcept C2776694085 @default.
• W2285208450 hasConcept C2778019345 @default.
• W2285208450 hasConcept C2778695046 @default.
• W2285208450 hasConcept C2778822529 @default.
• W2285208450 hasConcept C2779699572 @default.
• W2285208450 hasConcept C2779984678 @default.
• W2285208450 hasConcept C2780739268 @default.
• W2285208450 hasConcept C31760486 @default.
• W2285208450 hasConcept C535046627 @default.
• W2285208450 hasConcept C71924100 @default.
• W2285208450 hasConcept C90924648 @default.

• next